Thelansis’s "Nocturnal Enuresis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Nocturnal Enuresis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Nocturnal enuresis (NE) is a condition where an individual involuntarily loses urine while asleep after the age at which bladder control usually begins. NE can cause distress to both children and their families, and can have an adverse impact on behavior, social life, self-esteem, and emotional well-being. NE is common, especially at school entry age, but will spontaneously resolve in over 50% of children by the time they are 10 years old. The aetiology of NE is multifactorial and involves social, behavioral, genetic, and clinical factors. The most common risk factor is genetic/family history. In twin studies, identical twins showed greater concordance compared with non-identical twins (68% and 36%). If one parent has childhood NE, around 50% of their children are affected, increasing to 75% if both parents are affected. Some genetic loci for NE have been identified. The underlying pathophysiology of NE is understood as a complex combination of reduced nocturnal bladder capacity and nocturnal polyuria with sleep arousal difficulties, resulting in enuresis at different stages of the sleep cycle, not only in deep sleep.
G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)
*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.
1. Key Findings and Analyst Commentary
2. Disease Context
3. Epidemiology
4. Market Size and Forecast
5. Competitive Landscape
6. Unmet Need and TPP Analysis
7. Regulatory and Reimbursement Environments (by country and payer insights)
8. Appendix (e.g., bibliography, methodology)
No snapshots available.
That depends on the file type you choose: the Excel epidemiology model, the Excel market forecast model with dashboard, and the full analyst report in PowerPoint with a PDF version.
Within 48 to 72 hours of purchase.
Yes. Choose EU5, G7 or G8, or pick individual markets in the panel.
Yes. Request a free sample to preview the scope and sample pages.
Yes. The forecast model is customizable, and our analysts can tailor the scope to your questions.
Yes. Inquire for bundle discounted pricing and we will send you exclusive pricing for the reports you need.
Choose the file type you want to purchase or request.
No file type found.
Select markets to include.
No markets match your search.
Not sure which report fits your question? Our team will point you to the right one.
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
Prefer to talk it through? Email clientsupport@thelansis.com
You asked for for covering . We will reply to .
Fill in your details and our expert consultants will get in touch with you.
Get a sneak peek at the latest Nocturnal Enuresis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034 report
Our team will get in touch with you shortly about the Nocturnal Enuresis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034 report.